Country, language and currency
- Social bookmarks:
- Testimonials
-
You guys were superb and true to your word, happy to be a reference for you any time
and thank you
- David
Read more »
-
- Somaxon and CJ CheilJedang Announce Silenor(R) Collaboration in South Korea - MarketWatch (press release)
- Somaxon and CJ CheilJedang Announce Silenor(R) Collaboration in South KoreaMarketWatch (press release)Silenor is a low-dose (3 mg and 6 mg) oral tablet formulation of doxepin, and is the first and only non-scheduled prescription sleep medication approved to treat insomnia characterized by difficulties with sleep maintenance
- Infinite itch: Learning to live with hives - Sarasota Herald-Tribune
- Sarasota Herald-TribuneInfinite itch: Learning to live with hivesSarasota Herald-TribuneBut doxepin, the drug that finally suppressed the hives, made him so sleepy that he repeatedly dozed off on a desk during six weeks of job training
- Somaxon and CJ CheilJedang Announce Silenor® Collaboration in South Korea - SunHerald.com
- SunHerald
- Somaxon, CJ CheilJedang sign Silenor commercialization agreement - Pharmaceutical Business Review
- Somaxon, CJ CheilJedang sign Silenor commercialization agreementPharmaceutical Business ReviewSomaxon Pharmaceuticals and CJ CheilJedang have signed a commercialization agreement in South Korea for Silenor (doxepin) to treat insomnia
- Paladin Reports First Quarter 2012 Results Achieves Record Revenues - MarketWatch (press release)
- Paladin Reports First Quarter 2012 Results Achieves Record RevenuesMarketWatch (press release)Silenor(R) is a low-dose oral tablet formulation of doxepin indicated for the treatment and symptomatic relief of insomnia
